Old TB vaccine tested for surprising brain benefits in seniors
NCT ID NCT04507126
First seen Jan 04, 2026 · Last updated May 22, 2026 · Updated 17 times
Summary
This pilot study tested whether the BCG vaccine (used for tuberculosis) can change certain markers in the blood and spinal fluid of healthy older adults. Researchers measured immune responses and Alzheimer's-related proteins in 20 participants aged 55-80. The goal was to gather early data on how the vaccine might influence brain health, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Translational Research Unit
Charlestown, Massachusetts, 02124, United States
Conditions
Explore the condition pages connected to this study.